Guardion Health Sciences, Inc.
GHSI · OTC
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | |
|---|---|---|---|---|
| Market Cap | $12,700 | $11,612 | $6,810 | $9,398 |
| - Cash | $14,823 | $5,605 | $6,360 | $7,657 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | -$2,123 | $6,007 | $450 | $1,741 |
| Revenue | $73 | $3,000 | $2,936 | $3,337 |
| % Growth | -97.6% | 2.2% | -12% | – |
| Gross Profit | $36 | $1,179 | $1,345 | $1,460 |
| % Margin | 49.8% | 39.3% | 45.8% | 43.8% |
| EBITDA | -$1,363 | -$1,393 | -$687 | -$768 |
| % Margin | -1,869.1% | -46.4% | -23.4% | -23% |
| Net Income | $10,324 | -$4,747 | $425 | $373 |
| % Margin | 14,158.8% | -158.2% | 14.5% | 11.2% |
| EPS Diluted | 8.04 | -3.71 | 0.33 | 0.29 |
| % Growth | 316.7% | -1,224.2% | 13.8% | – |
| Operating Cash Flow | -$1,080 | -$755 | -$1,318 | -$767 |
| Capital Expenditures | -$0 | $0 | $0 | $0 |
| Free Cash Flow | -$1,080 | -$755 | -$1,318 | -$767 |